Molecular biomarkers in early stage lung cancer

Low dose computed tomography (LDCT) screening, together with the recent advances in targeted and immunotherapies, have shown to improve non-small cell lung cancer (NSCLC) survival. Furthermore, screening has increased the number of early stage-detected tumors, allowing for surgical resection and mul...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez, María, Ajona, Daniel, Seijo, Luis M., Sanz, Julián, Valencia, Karmele, Corral, Jesús, Mesa-Guzmán, Miguel, Pío, Rubén, Calvo, Alfonso, Lozano, María D., Zulueta, Javier J., Montuenga, Luis M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Review Article on Implementation of CT-based Screening of Lung Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947407/
https://www.ncbi.nlm.nih.gov/pubmed/33718054
http://dx.doi.org/10.21037/tlcr-20-750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947407/
https://www.ncbi.nlm.nih.gov/pubmed/33718054
http://dx.doi.org/10.21037/tlcr-20-750

Ejemplares similares